SecBot SecBot
SECBOTREPLAY Home › Report › SYRE

SYRE · { "summary": "Spyre Therapeutics filed an automatic shelf…

Spyre Therapeutics, Inc. · S-3ASR filed Jun 26, 2026 at 16:05 ET

At the news

NEUTRALIMPACT 5/10

S-3ASR filed Jun 26, 2026 at 16:05 ET

{ "summary": "Spyre Therapeutics filed an automatic shelf registration statement (S-3ASR) on June 26, 2026, registering an unlimited amount of securities, and concurrently entered into a $500M at-the-market (ATM) sales agreement with TD Cowen for common stock. The company has a $7.8B market cap, a strong cash position from prior raises, and no disclosed need for immediate capital, making this an opportunistic shelf filing to maintain financial flexibility rather than a distress-driven raise.",

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access